Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Century Casinos Q4 2025 Earnings Call - Adjusted EBITDAR Up Despite Licensing and Sports Betting Headwinds, Powered by Missouri and Nugget Rebounds
Century Casinos closed 2025 with adjusted EBITDAR up 3% year over year, a result management calls resilient given the loss of Colorado sports betting income and licensing disruptions in Poland. The qu...
- Adjusted EBITDAR for full-year 2025 rose 3% year over year, and would have been roughly 5% higher excluding lost Colorado sports betting income and Poland licensing disruptions.
- Fourth quarter adjusted EBITDAR increased 13% despite flat net operating revenue, which management attributes to unusually poor winter weather in December that dented top line.
- Century’s Missouri cluster led the story: Caruthersville grew from about $12 million implied EBITDAR at acquisition to roughly $24.4 million in 2025, effectively doubling within six years after a land-based transition completed in November 2024.
- +11 more takeaways
Bimini Capital Management Q4 2025 Earnings Call - Buying TJIM and Shrinking RMBS: a Clear Pivot Toward Advisory Revenue
Bimini used a strong 2025 fixed-income backdrop and a dramatic surge at Orchid Island to fund a strategic pivot. Management announced an agreement for a subsidiary to buy 80% of Tom Johnson Investment...
- Bimini announced an agreement for a subsidiary to acquire 80% of Tom Johnson Investment Management, LLC, an RIA with approximately $1.6 billion in AUM, expected to close early Q2 2026.
- The acquisition will be funded with cash on hand and Royal Palm capital; management said no borrowings will be used to close the deal.
- To finance the purchase, Bimini plans to liquidate the majority of its agency RMBS portfolio, meaning the company will significantly shrink that business line and reduce leverage going forward.
- +12 more takeaways
The Buckle, Inc. Fourth Quarter 2026 Earnings Call - Women’s denim lifts comps as inventory and expansion pick up pace
Buckle delivered a muted but constructive quarter. Q4 net income rose to $80.8 million, sales grew 5.3% and comparable store sales increased 3.9%, driven by a fifth consecutive quarter of double-digit...
- Q4 net income was $80.8 million, or $1.59 per diluted share, up from $77.2 million, or $1.53, in the prior-year quarter.
- Full fiscal year net income was $209.7 million, or $4.14 per diluted share, versus $195.5 million, or $3.89, last year.
- Quarterly net sales rose 5.3% to $399.1 million; full-year sales increased 6.6% to $1.298 billion.
- +14 more takeaways
Better Home & Finance Holding Company Q4 2025 Earnings Call - Tinman AI platform ramps, targeting $1B/month by May 2026 and Adjusted EBITDA breakeven by Q3 2026
Better presented a clear pivot in Q4 2025, from a direct-to-consumer mortgage originator to an AI-native platform provider. Q4 funded volume reached $1.5 billion and revenue was $44 million, driven ma...
- Q4 2025 results: $1.5 billion funded loan volume, $44 million revenue, up 56% and 77% year-over-year respectively.
- Full year 2025: $4.7 billion funded volume and $165 million revenue, up 32% and 52% year-over-year. The end of the Ally partnership represented roughly a $1 billion headwind to volume.
- Tinman AI platform momentum: Tinman generated $646 million of volume in Q4 2025, over 40% of total Q4 volume, surpassing prior guidance of $600 million.
- +16 more takeaways
The ONE Group Hospitality Q4 2025 Earnings Call - Execution-led inflection but near-term pain from portfolio pruning and impairments
The ONE Group closed 2025 with clear operational momentum, driven by Benihana integration and STK strength, but the quarter carried the cost of deliberate portfolio optimization and a non-cash impairm...
- Full-year 2025 GAAP revenue was approximately $805 million, up about 20% year over year driven primarily by Benihana being included for all twelve periods.
- Q4 2025 GAAP revenue was $207 million, down 6.7% from $222 million year over year, with about 35% of the decline attributed to portfolio optimization closures and roughly $5.7 million (37% of the Q4 revenue drop) due to a fiscal calendar shift that moved New Year’s Eve into fiscal 2026.
- Consolidated comparable sales declined 1.8% in Q4 but improved by roughly 4 percentage points sequentially from Q3, and year-to-date consolidated comps have turned slightly positive, which management calls an inflection point.
- +14 more takeaways
VEON Q4 2025 Earnings Call - Digital Services Scale to Profitability as EBITDA Tops $2bn
VEON closed 2025 with clear momentum. Group revenues reached $4.4 billion, up 9.9% in dollars, and group EBITDA crossed the $2.0 billion mark with a 45.7% margin. The company said digital services are...
- Group revenue $4.4bn in 2025, up 9.9% year-over-year in US dollars.
- Group EBITDA exceeded $2.0bn for 2025, up 18.8% year-over-year, with EBITDA margin at 45.7%.
- Digital revenues reached $759m in 2025, up >62% year-over-year, representing 17% of group revenue for the year and over 20% in Q4.
- +15 more takeaways
Emerald Holding Q4 and Full Year 2025 Earnings Call - Portfolio reshaped for cash-generative growth
Emerald closed a transformational 2025, reshaping its portfolio through three strategic acquisitions and exits, and delivered revenue of $463.4 million and adjusted EBITDA of $127.1 million for the ye...
- 2025 was positioned as transformational, driven by portfolio reshaping and targeted tuck-in acquisitions: This is Beyond, InsurTech Insights, and Generis.
- Full year 2025 revenue was $463.4 million, up 16.2% year-over-year, with adjusted EBITDA of $127.1 million, a 25% increase versus prior year.
- Reported organic revenue growth for full year 2025 was 1.1%. On a pro forma basis including 2025 acquisitions, organic revenue would have been up 4.8% for the year.
- +12 more takeaways
Acurx Pharmaceuticals Q4 2025 Earnings Call - Ibezapolstat enters rCDI pilot aiming to both treat and prevent recurrence
Acurx used the quarter to shift from promising proof points to an operational push, launching a 20-patient open-label pilot in recurrent C. difficile infection that is explicitly designed to position ...
- Acurx has launched a 20-patient open-label pilot in recurrent C. difficile infection, intended to inform a planned active-controlled phase 3 in rCDI.
- Primary efficacy endpoint for recurrence will be measured at 8 weeks, with additional follow-up out to about 6 months for durability data.
- Treatment period in the rCDI pilot is 14 days, longer than prior 10-day regimens, aimed at boosting initial cure rates and powering recurrence analysis.
- +13 more takeaways
RLX Technology Inc. Q4 2025 Earnings Call - International sales 76.5% of revenue, fueling margin expansion and $2.2B cash
RLX closed 2025 with a clean, fast-growing story. Q4 net revenue rose 40.3% year over year to RMB 1.14 billion, and full-year revenue grew 44% to RMB 3.96 billion. Management’s game this year was glob...
- Q4 2025 net revenues RMB 1.14 billion, up 40.3% year-over-year; full-year revenues RMB 3.96 billion, up 44%.
- International sales were 76.5% of Q4 revenue, marking RLX’s transition to a truly global company.
- Gross margin expanded to 31.4% in Q4 from 27% a year ago, full-year gross margin rose to 29.9%.
- +12 more takeaways
Douglas Elliman Q4 2025 Earnings Call - Profitability Restored via Property Management Sale; Adjusted EBITDA Still Negative
Douglas Elliman closed 2025 with a cleaner balance sheet and a headline-grabbing net income helped by the October sale of its property management business. Revenue climbed modestly to $1.033 billion, ...
- Headline profitability in 2025 was materially supported by an $81.7 million gain from the October sale of the property management business.
- Revenue for 2025 rose 3.8% year-over-year to $1.033 billion; excluding the disposed business, revenues increased 4.4% to $1.0 billion.
- Operating income turned positive at $45.5 million in 2025 versus an operating loss of $68.8 million in 2024, but this includes the divestiture gain.
- +12 more takeaways